While the Fountain of Youth may not have been found, an investigational pill may be able to keep you healthy to 100 years old. RCR is excited to be a part of this cutting-edge research, as we hope to find a medicine to keep you healthy, longer.
In the latest AARP issue, an article titled Can a Single Pill Keep you Healthy to 100? (We May Soon Find Out) by Sari Harrar discussed RTB101, an investigational drug developed by resTORbio, has been studied in clinical trials over the past 15 years. The drug arrests aging at a cellular level, leading not to a longer life, but a better life. The drug is aimed at reducing the risk for respiratory diseases. Today, respiratory tract infections send over 1 Million older adults to the hospital every year and kill more that 75,000. As the number of adults over the age of 65 in the US increase, the need for this drug has also increased. According to the article, the drug may win FDA approval as early as 2021. Rochester Clinical Research recently participate in one of the RTB101 clinical trials in 2015. In the article, one of RCR’s volunteers, Ken, was featured and spoke about his experience with the trial. A link to the article from AARP can be found here.
Rochester Clinical Research will be conducting another RTB101 clinical trial in the Fall 2019. If you are interested in joining the trial, please call 585-288-0890 to learn more and to be added to an interest listRochester Clinical Research will be conducting another RTB101 clinical trial in the Fall 2019. If you are interested in joining the trial, please click here or call 585-288-0890 to be added to an interest list.
